However, the tumor tissues in the GAA treatment group and the combination group showed lower levels of LRPPRC and CDK6 than the control group and CDK4/6i monotherapy group, suggesting that the addition of GAA can also block the LRPPRC-CDK6 feedback loop in vivo. The gene discussed is CDK6; the disease is neoplasm.